Filing Details
- Accession Number:
- 0000885590-11-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-17 17:02:55
- Reporting Period:
- 2011-05-13
- Filing Date:
- 2011-05-17
- Accepted Time:
- 2011-05-17 16:02:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1343811 | Ann Norma Provencio | C/O 7150 Mississauga Road Mississauga A6 L5N 8M5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2011-05-13 | 1,000 | $51.24 | 154,007 | No | 4 | P | Direct | |
Common Stock, No Par Value | Acquisiton | 2011-05-16 | 1,000 | $49.85 | 155,007 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Common Stock held in the reporting person's 401k account.
- 102,353 of these represent restricted share units held by the reporting person, which were previously reported in Table 1.